PPARG protein expression in advanced urothelial carcinoma and selection for response to FX-909, a first-in-class PPARG-targeting agent.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Evisa Gjini, William Motley, Adarsh Joshi, Bijal Kakrecha, Jennifer Mertz, Kaylyn Williamson, Stefan Kirov, Michaela Bowden
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4407701626